ZYDELIG

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, United Kingdom, United States

Active ingredients

The drug ZYDELIG contains one active pharmaceutical ingredient (API):

1 Idelalisib UNII YG57I8T5M0 - IDELALISIB

Idelalisib inhibits phosphatidylinositol 3-kinase p110δ (PI3Kδ), which is hyperactive in B-cell malignancies and is central to multiple signalling pathways that drive proliferation, survival, homing, and retention of malignant cells in lymphoid tissues and bone marrow. Idelalisib induces apoptosis and inhibits proliferation in cell lines derived from malignant B-cells and in primary tumour cells. Read about Idelalisib

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZYDELIG Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EM01		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors
Discover more medicines within L01EM01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11162L, 11165P, 11170X, 11171Y
Country: CA	Health Products and Food Branch	Identifier(s): 02438798, 02438801
Country: EE	Ravimiamet	Identifier(s): 1664883, 1664894
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114938001, 114938002
Country: FR	Base de données publique des médicaments	Identifier(s): 68093737, 69111017
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 347180, 347184
Country: IE	Health Products Regulatory Authority	Identifier(s): 88299, 88333
Country: IT	Agenzia del Farmaco	Identifier(s): 043620018, 043620020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1074493, 1074494
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 120103, 120111
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17527, 17529
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100327258, 100327264
Country: US	FDA, National Drug Code	Identifier(s): 61958-1701, 61958-1702